Leading Medical Journal Prints Article on Avandia Drug Side Effects

In recent Avandia news, on June 5, 2007, the New England Journal of Medicine responded to a medical study that sought to put to rest the fear that the Type 2 diabetes drug Avandia had serious heart-related side effects. The journal's authors found that the study did not alleviate the concern that the medicine raised the risk of a heart attack or death from cardiovascular disease in users.

In the article "Rosiglitazone--Continued Uncertainty about Safety," authors Jeffrey M. Drazen, M.D., Stephen Morrissey, Ph.D. and Gregory D. Curfman, M.D. conclude that "there is continued uncertainty about the cardiovascular safety of rosiglitazone (Avandia)."

The authors additionally caution about the seriousness of deeming a drug safe for public consumption without fully assessing the research: "In this age of freely available information, drugs cannot easily be parsed into 'safe' and 'unsafe' categories."

Instead, they say, there will be shades of safety that must be graded against the shades of efficacy.

If you or a loved one has suffered Avandia side effects or cardiac complications after ingesting Avandia, you deserve the guidance of an experienced drug attorney. Get a free case review by filling out the form below.

Click To Talk To Us Online

see also:

NEJM Update, 6.5.07 Leading Medical Journal Prints Article on Avandia Drug Side Effects
Further Questions Revealed on Avandia Drug Side Effects, Says Journal

NEJM Study Avandia Drug NEJM Study | Weitz & Luxenberg
Study on Rosiglitazone (Avandia) Medication and Risk of Cardiac Issues